THE DDI SERODOT RUBELLA IGG TEST KIT— 510(k) K875368

Name: FDA 510(k) clearance K875368
Creator: U.S. Food and Drug Administration
Published: 1988-03-23

Substantially Equivalent

Disease Detection International, Inc.

FDA 510(k) clearance K875368 for THE DDI SERODOT RUBELLA IGG TEST KIT, Substantially Equivalent on 1988-03-23. Applicant: Disease Detection International, Inc.. Device class: 2.

Clearance details

Applicant: Disease Detection International, Inc.
Product code: Code LFX
Device class: Class 2
Regulation: 21 CFR 866.3510
Advisory panel: Microbiology
Date received: 1987-12-31
Decision date: 1988-03-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LFX

view all

K250588 — Access Rubella IgG2025-11-17
K243168 — Alinity i Rubella IgG2025-06-20
K122397 — LIAISON RUBELLA IGM, LIAISON CONTROL RUBELLA IGM2012-09-06
K093101 — MAGO 4S2011-01-21
K092587 — BIOPLEX 2200 RUBELLA & CMV IGM KIT ON THE BIOPLEX 2200 MULTI ANALYTE DETECTION SYSTEM2010-12-03

More clearances from Disease Detection International, Inc.

view all

K943252 — PRO-STEP LH OVULATION PREDICTION TEST1994-10-25
K925303 — PRO-STEP PT HCG1993-06-15
K925125 — PRO-STEP HCG1993-01-13
K911826 — IMMUNOCARD HCG ONE STEP (I-S) TEST KIT1991-07-19
K902571 — MODIFICATION OF SEROCARD RUBELLA IGG TEST1990-09-05

Data sourced from openFDA. This site is unofficial and independent of the FDA.